Oxyphyllanene C

Details

Top
Internal ID d5d8c4e6-c720-4eb1-9562-48b008612c39
Taxonomy Organoheterocyclic compounds > Oxepanes
IUPAC Name (1aS,3aS,7bR)-1a-acetyl-3a,7-dimethyl-3,4,5,7b-tetrahydro-2H-naphtho[1,2-b]oxiren-6-one
SMILES (Canonical) CC1=C2C3C(O3)(CCC2(CCC1=O)C)C(=O)C
SMILES (Isomeric) CC1=C2[C@@H]3[C@@](O3)(CC[C@]2(CCC1=O)C)C(=O)C
InChI InChI=1S/C14H18O3/c1-8-10(16)4-5-13(3)6-7-14(9(2)15)12(17-14)11(8)13/h12H,4-7H2,1-3H3/t12-,13-,14-/m1/s1
InChI Key WEPFDGKIDPCING-MGPQQGTHSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C14H18O3
Molecular Weight 234.29 g/mol
Exact Mass 234.125594432 g/mol
Topological Polar Surface Area (TPSA) 46.70 Ų
XlogP 0.70
Atomic LogP (AlogP) 2.19
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
CHEMBL1949796
(1aS,7bR)-1a-Acetyl-1a,2,3,3a,4,7b-hexahydro-3aalpha,7-dimethylnaphtho[1,2-b]oxirene-6(5H)-one

2D Structure

Top
2D Structure of Oxyphyllanene C

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9954 99.54%
Caco-2 + 0.7721 77.21%
Blood Brain Barrier + 0.7000 70.00%
Human oral bioavailability + 0.5714 57.14%
Subcellular localzation Mitochondria 0.6524 65.24%
OATP2B1 inhibitior - 0.8482 84.82%
OATP1B1 inhibitior + 0.9139 91.39%
OATP1B3 inhibitior + 0.9844 98.44%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior + 0.5500 55.00%
BSEP inhibitior - 0.9195 91.95%
P-glycoprotein inhibitior - 0.9121 91.21%
P-glycoprotein substrate - 0.9253 92.53%
CYP3A4 substrate + 0.5713 57.13%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8632 86.32%
CYP3A4 inhibition - 0.8431 84.31%
CYP2C9 inhibition - 0.8104 81.04%
CYP2C19 inhibition - 0.7770 77.70%
CYP2D6 inhibition - 0.9387 93.87%
CYP1A2 inhibition - 0.5000 50.00%
CYP2C8 inhibition - 0.9066 90.66%
CYP inhibitory promiscuity - 0.8989 89.89%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.5486 54.86%
Eye corrosion - 0.9877 98.77%
Eye irritation + 0.5719 57.19%
Skin irritation - 0.5228 52.28%
Skin corrosion - 0.9206 92.06%
Ames mutagenesis - 0.6682 66.82%
Human Ether-a-go-go-Related Gene inhibition - 0.7044 70.44%
Micronuclear - 0.6500 65.00%
Hepatotoxicity + 0.5336 53.36%
skin sensitisation - 0.6641 66.41%
Respiratory toxicity - 0.6333 63.33%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.8125 81.25%
Nephrotoxicity + 0.5209 52.09%
Acute Oral Toxicity (c) III 0.5807 58.07%
Estrogen receptor binding - 0.6879 68.79%
Androgen receptor binding + 0.5581 55.81%
Thyroid receptor binding - 0.6574 65.74%
Glucocorticoid receptor binding - 0.6428 64.28%
Aromatase binding - 0.7855 78.55%
PPAR gamma - 0.6032 60.32%
Honey bee toxicity - 0.8731 87.31%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.7000 70.00%
Fish aquatic toxicity + 0.9866 98.66%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.61% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 89.02% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.19% 95.56%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 85.87% 99.23%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 85.14% 85.14%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.18% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.87% 89.00%
CHEMBL340 P08684 Cytochrome P450 3A4 80.40% 91.19%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.05% 97.09%

Cross-Links

Top
PubChem 57335616
NPASS NPC60951
LOTUS LTS0076628
wikiData Q105303280